InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Koch Kevin. Officer active across 1 company, notably Edgewise Therapeutics, Inc.. In total, 11 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €680k. History available since 1 May 2023. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
KOCH KEVIN is a declarant linked to Edgewise Therapeutics, Inc., where he is President and CEO. The record shows 5 filings in total, and the sampled recent filings run from 2023-05-03 to 2025-05-07, with the modal transaction nature listed as option exercise.